Work

Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.

Year: 2012

Type: article

Source: PubMed

Authors: Toshihiro Fukushima, Hiroshi Kawabata, Toshioki Sawaki, Tomomi Satoh, Takuji Nakamura, Haruka Iwao, Akio Nakajima, Tomoyuki Sakai, Miyuki Miki, Yoshimasa Fujita, Masao Tanaka, Takafumi Kawanami, Yasufumi Masaki, Toshiro Okazaki, Hisanori Umehara

Institution: Kanazawa Medical University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2156161928

FWCI: 0.614

Cites: 24

Cited by: 11

Related to: 10